Alladapt Immunotherapeutics Overview
- Year Founded
-
2018
- Status
-
Private
- Employees
-
46
- Latest Deal Type
-
Liquidation
Alladapt Immunotherapeutics General Information
Description
Developer of prescription therapeutics designed to target food allergies. The company's medication is being advanced as a broad-spectrum oral immunotherapy treatment to mitigate food allergies triggered by single or multiple proteins from an expansive set of common allergens, enabling doctors to effectively treat patients with various allergies.
Contact Information
Website
www.alladapt.comCorporate Office
- 405 El Camino Real
- Suite 611
- Menlo Park, CA 94025
- United States
Corporate Office
- 405 El Camino Real
- Suite 611
- Menlo Park, CA 94025
- United States
Alladapt Immunotherapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Bankruptcy: Liquidation | 23-Jul-2024 | Completed | Bankruptcy: Liquidation | |||
| 5. Debt - General | 24-Aug-2022 | Completed | Generating Revenue | |||
| 4. Later Stage VC (Series D) | 05-May-2022 | Completed | Generating Revenue | |||
| 3. Later Stage VC (Series C) | 19-Feb-2020 | Completed | Generating Revenue | |||
| 2. Early Stage VC (Series B) | 20-Mar-2018 | $1.1M | $1.5M | Completed | Generating Revenue | |
| 1. Early Stage VC (Series A) | $400K | $400K | Completed | Startup |
Alladapt Immunotherapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series D-2 | ||||||||
| Series D-1 | ||||||||
| Series D | ||||||||
| Series C | ||||||||
| Series B | 12,499,993 | $0.000100 | $0.01 | $0.1 | $0.1 | 1x | $0.1 | 3.04% |
| Series A | 9,365,072 | $0.000100 | $0 | $0.05 | $0.05 | 1x | $0.05 | 2.28% |
Alladapt Immunotherapeutics Comparisons
Industry
Financing
Details
Alladapt Immunotherapeutics Competitors (23)
One of Alladapt Immunotherapeutics’s 23 competitors is ClostraBio, a Venture Capital-Backed company based in Chicago, IL.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| ClostraBio | Venture Capital-Backed | Chicago, IL | ||||
| Actym Therapeutics | Venture Capital-Backed | Berkeley, CA | ||||
| Elevar Therapeutics | Formerly VC-backed | Fort Lee, NJ | ||||
| Immunomic Therapeutics | Venture Capital-Backed | Rockville, MD | ||||
| Byondis | Corporation | Nijmegen, Netherlands |
Alladapt Immunotherapeutics Patents
Alladapt Immunotherapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2024186702-A1 | Methods of treating allergies | Inactive | 03-Mar-2023 | ||
| US-20240133898-A1 | Compositions and methods for identification of cross-reactive allergenic proteins and treatment of allergies | Inactive | 24-Feb-2021 | ||
| US-20240230671-A9 | Compositions and methods for identification of cross-reactive allergenic proteins and treatment of allergies | Inactive | 24-Feb-2021 | ||
| WO-2022182872-A2 | Compositions and methods for identification of cross-reactive allergenic proteins and treatment of allergies | Inactive | 24-Feb-2021 | ||
| WO-2022182872-A3 | Compositions and methods for identification of cross-reactive allergenic proteins and treatment of allergies | Inactive | 24-Feb-2021 | G01N33/6854 |
Alladapt Immunotherapeutics Signals
Alladapt Immunotherapeutics FAQs
-
When was Alladapt Immunotherapeutics founded?
Alladapt Immunotherapeutics was founded in 2018.
-
Where is Alladapt Immunotherapeutics headquartered?
Alladapt Immunotherapeutics is headquartered in Menlo Park, CA.
-
What is the size of Alladapt Immunotherapeutics?
Alladapt Immunotherapeutics has 46 total employees.
-
What industry is Alladapt Immunotherapeutics in?
Alladapt Immunotherapeutics’s primary industry is Drug Discovery.
-
Is Alladapt Immunotherapeutics a private or public company?
Alladapt Immunotherapeutics is a Private company.
-
What is Alladapt Immunotherapeutics’s current revenue?
The current revenue for Alladapt Immunotherapeutics is .
-
How much funding has Alladapt Immunotherapeutics raised over time?
Alladapt Immunotherapeutics has raised $230M.
-
Who are Alladapt Immunotherapeutics’s competitors?
ClostraBio, Actym Therapeutics, Elevar Therapeutics, Immunomic Therapeutics, and Byondis are some of the 23 competitors of Alladapt Immunotherapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process